|
Rapisuwon, Suthee; Vietsch, Eveline E; Wellstein, Anton (2016) Circulating biomarkers to monitor cancer progression and treatment. Comput Struct Biotechnol J 14:211-22
|
|
LaConti, Joseph J; Laiakis, Evagelia C; Mays, Anne Deslattes et al. (2015) Distinct serum metabolomics profiles associated with malignant progression in the KrasG12D mouse model of pancreatic ductal adenocarcinoma. BMC Genomics 16 Suppl 1:S1
|
|
Sharif, G M; Schmidt, M O; Yi, C et al. (2015) Cell growth density modulates cancer cell vascular invasion via Hippo pathway activity and CXCR2 signaling. Oncogene 34:5879-89
|
|
Vietsch, Eveline E; van Eijck, Casper Hj; Wellstein, Anton (2015) Circulating DNA and Micro-RNA in Patients with Pancreatic Cancer. Pancreat Disord Ther 5:
|
|
Shivapurkar, Narayan; Weiner, Louis M; Marshall, John L et al. (2014) Recurrence of early stage colon cancer predicted by expression pattern of circulating microRNAs. PLoS One 9:e84686
|
|
Shivapurkar, N; Mikhail, S; Navarro, R et al. (2013) Decrease in blood miR-296 predicts chemotherapy resistance and poor clinical outcome in patients receiving systemic chemotherapy for metastatic colon cancer. Int J Colorectal Dis 28:887
|
|
Wellstein, Anton (2012) ALK receptor activation, ligands and therapeutic targeting in glioblastoma and in other cancers. Front Oncol 2:192
|
|
LaConti, Joseph J; Shivapurkar, Narayan; Preet, Anju et al. (2011) Tissue and serum microRNAs in the Kras(G12D) transgenic animal model and in patients with pancreatic cancer. PLoS One 6:e20687
|
|
Wellstein, Anton; Toretsky, Jeffrey A (2011) Hunting ALK to feed targeted cancer therapy. Nat Med 17:290-1
|
|
Stylianou, D C; Auf der Maur, A; Kodack, D P et al. (2009) Effect of single-chain antibody targeting of the ligand-binding domain in the anaplastic lymphoma kinase receptor. Oncogene 28:3296-306
|
Showing the most recent 10 out of 11 publications
